The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has established the Drug-Induced Liver Injury Network (DILIN) to collect and analyze cases of severe liver injury caused by prescription drugs, over-the-counter drugs, and alternative medicines, such as herbal products and supplements.
Current Studies:
|
Prospective DILIN
Enrolling: Yes
Principal Investigator: Dr. Naga Chalasani
Duration: 6 - 24 months
Patient Population: NAS > 4
|
Contact:
Allison White
(317) 278-6266
whitalli@iu.edu
|
|
Prospective Acute DILIN
Enrolling: Yes
Principle Investigator: Dr. Naga Chalasani
Duration: 6 - 24 months
Patient Population: DILI enrolled within 16 days of date of onset.
|
Contact:
Allison White
(317) 278-6266
whitalli@iu.edu
|
|
Retrospective Acute DILIN
Enrolling: Yes
Principle Investigator: Dr. Naga Chalasani
Duration: 1 visit.
Patient Population: DILI beyond 6 months of event, back to January 1, 1994.
|
Contact:
Allison White
(317) 278-6266
whitalli@iu.edu
|